Jan 20, 2026
What adverse events have been reported to the FDA related to compounded tirzepatide, and which compounding pharmacies were involved?
Compounded tirzepatide has been linked in FDA reporting to hundreds of adverse event reports—most commonly gastrointestinal complaints, dosing-error–related harms, and some hospitalizations and deaths...